Linkedin
  • phone (+48) 71 325 62 42
Search
  • About the company
  • Our services

    R&D services

    Development of a medicinal product,
    Design of research methods,
    Preformulation/deformulation, Stability studies

    Analytical studies

    Particle shape and size analysis,
    Chromatographic analyses,
    X-ray analyses,
    Release studies

    Technological tasks

    Mixing of dry forms,
    Mixing and homogenization of liquid and semi-solid forms,
    Granulation of powders,
    Manufacture of tablets

    GMP System

    Quality control testing of the finished product and starting materials 

    more...
    more...
    more...
    more...
  • News
  • Scientific work
  • Career
  • Other
  • Contact

History

2022
In April 2022, Novasome R&D Centre joins the Polish Chamber of Chemical Industry, supporting the development and innovation of the chemical R&D industry.
2022
2021
In December 2021, Novasome R&D Centre becomes a member of LifeScience Kraków Cluster, which supports entrepreneurship and innovation of the institutions involved in life sciences.
2021
2021
Novasome R&D Centre receives funding for a project on the synthesis of active pharmaceutical ingredients (API’s). The project is run in consortium with Pikralida.
2021
2019
Inclusion of Novasome R&D in the POL-on Register of Scientific Units, an integrated system of information about science and higher education.
2019
2018
By the decision of the Ministry of Science and Higher Education, Novasome R&D Centre is granted the status of a scientific unit.
2018
2017
In June 2017, the Chief Pharmaceutical Inspectorate grants Novasome R&D Centre a certificate of Good Manufacturing Practices (GMP), a quality controlled manufacturing authorization (physico-chemical testing)
2017
2016
The Laboratory of Innovative Medical Technologies (LITM) was created within the company’s structure. The purpose of LITM is to conduct interdisciplinary research and development, as well as implementation work in order to seek innovative solutions in the field of medicine, biotechnology and related sciences.
2016
2016
Novasome R&DC became a member of the Nutribiomed Cluster, associating a group of enterprises from the food, biotechnological and biomedical sectors.
2016
2014
By a decision of the Minister of Economy, Novasome R&DC obtained the official status of a Research and Development Centre.
2014
2008
In 2008, Novasome R&DC received funding for the project ‘Transformation of Novasome R&DC into a Research and Development Centre’.. As part of the project, new laboratories were created, and existing laboratories were expanded and modernised.
2008
2007
Since 2007, a number of research projects carried out by Novasome R&DC have been conducted at the request of P.P.F. Hasco-Lek S.A., including as part of the implementation of the tasks of the Technological Initiative I project co-financed by the Ministry of Science and Higher Education
2007
2006
In 2006, the company’s shareholder structure changed under another notarial deed. Since then, Polish capital has been fully involved in the company. After this, the main area of the company’s business became research and development projects in the field of medical sciences, pharmacy and cosmetics.
2006
2004
Novasome Research and Development Centre Sp. z o.o. was established in November 2004 as a spin-off company. The company’s roots date back to the Academic Centre for Biotechnology of Lipid Aggregates created in 2001 The consortium was established by the research teams of the University of Wrocław, Wrocław University of Environmental and Life Sciences, Wroclaw Medical University and Wrocław University of Science and Technology. The company’s main purpose was to conduct basic and application research in the field of nanotechnology.
2004
Head office

Centrum Badawczo-Rozwojowe “NOVASOME” Sp. z o.o.

Novasome R&D Centre


ul. Olsztyńska 5
51-423 Wrocław

tel. (+48) 71 325 62 42
e-mail: biuro@cbr.novasome.pl

Numer BDO: 000027336
REGON: 933042938
NIP: 8982061354
KRS: 0000225784

Linkedin
Manage your privacy settings
Contact form

The administrator of your personal data provided in the form is the Centrum Badawczo-Rozwojowe "NOVASOME" Sp. z o.o. with its registered office in Wrocław 51-423, ul. Olsztyńska 5. Your personal data will be processed for the purpose of responding to your message. Detailed information on the processing of personal data can be found at https://novasome.pl/polityka-prywatnosci/.

© Copyright 2022 by CBR Novsome sp. z o.o.

Privacy policy

Novasome

Linkedin

 Grupa Hasco

Facebook Linkedin